Prevalence of enteric infections among hospitalized patients in two referral hospitals in Ghana

BMC Research Notes

Table 4 Antimicrobial susceptibility testing results for Salmonella sp. and Plesiomonas sp.

Antimicrobial agent	Disk conten (μg)	Inhibition zone diameter for different pathogens (mm)^b
Antimicrobial agent	Disk conten (μg)	Salmonella sp. 1	Salmonella sp. 2	Plesiomonas sp. 1	Plesiomonas sp. 2
Amikacin	30	18	17	12^a	12^a
Ampicillin	10	8^a	9^a	8^a	8^a
Ampicillin–sulbactam	10/10	18	18	17	19
Aztreonam	30	14^a	12^a	13^a	14^a
Cefotaxime	30	28	27	30	29
Cephalothin	30	20	21	11^a	12^a
Chloramphenicol	30	9^a	9^a	15	16
Ciprofloxacin	5	12^a	11^a	24	23
Gentamycin	10	14	13	8^a	8^a
Imipenem	10	26	24	17^a	15^a
Nalidixic acid	30	10^a	9^a	9^a	8^a
Tetracycline	30	8^a	8^a	10^a	9^a
Trimethoprim/sulfamethoxazole	23.75	18	19	8^a	8^a

^aResistant
^bCut-off inhibition zone diameter values determined using the performance standards for antimicrobial susceptibility testing twenty-first informational supplement for CLSI [12]

ISSN: 1756-0500